Preview
Sign-in for full Details 
Sign-in free and Explore the Exciting World of BiomedExperts:
- Over 1.500.000 Profiles
- More than 1.800 Organizations worldwide
- State of the Art Network Visualizations
- Manage your own Profile
- Locate Experts in your Country/Region
- Locate Experts in your 1. and 2. Level Network
- Connect to Experts Worldwide
NetworkView
Salut Brunet
This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers
together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles
free of charge to researchers worldwide.
Research Profile (preview)
Procedures
Disorders
Concepts & Ideas
Chemicals & Drugs
Phenomena
Sign-in to see full Profile
Network (preview)
80
Sierra, Jorge
74
Martino, Rodrigo
72
Sureda, Anna
33
Domingo-Albós, A
27
Nomdedéu, Josep
26
Altés, Albert
23
Caballero, Dolores
22
de la Rubia, Javier
21
Solano, Carlos
20
Sanz, Miguel
19
Briones, Javier
18
Bargay, Joan
18
Espigado, Ildefonso
18
Martínez, Carmen
17
Badell, Isabel
Sign-in to see all Coauthors
Publications
Sign-in to see all Publications
Sign in free and see...
Visualized networks:
See your personal network in
sophisticated graphical views
GeoTargeted Searches:
Locate experts around the world
and connect with global collaborators
Research Profiles:
See the visualized research activity
of experts around the globe
Sign-in to see more
Geonetwork of Salut Brunet (preview)
Cities where this author has publications
Cities where co-authors of this author have publications
Sign-in to see more
All Publications
-
2009: Lasa Adriana; Carricondo Maite; Estivill Camino; Bussaglia Elena; Gich Ignasi; Brunet Salut; Aventin Anna; Sierra Jorge; Nomdedéu Josep F
WT1 monitoring in core binding factor AML: comparison with specific chimeric products.
Leukemia research 2009;33(12):1643-9.
-
2009: Barba Pere; Piñana Jose Luis; Valcárcel David; Querol Luis; Martino Rodrigo; Sureda Anna; Briones Javier; Delgado Julio; Brunet Salut; Sierra Jorge
Early and late neurological complications after reduced-intensity conditioning allogeneic stem cell transplantation.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2009;15(11):1439-46.
-
2009: Gallardo David; de la Cámara Rafael; Nieto Jose B; Espigado Ildefonso; Iriondo Arturo; Jiménez-Velasco Antonio; Vallejo Carlos; Martín Carmen; Caballero Dolores; Brunet Salut; Serrano David; Solano Carlos; Ribera Josep M; de la Rubia Javier; Carreras Enric
Is mobilized peripheral blood comparable with bone marrow as a source of hematopoietic stem cells for allogeneic transplantation from HLA-identical sibling donors? A case-control study.
Haematologica 2009;94(9):1282-8.
-
2009: Montesinos Pau; Díaz-Mediavilla Joaquín; Debén Guillermo; Prates Virginia; Tormo Mar; Rubio Vicente; Pérez Inmaculada; Fernández Isolda; Viguria Maricruz; Rayón Chelo; González José; de la Serna Javier; Esteve Jordi; Bergua Juan M; Rivas Concha; González Marcos; González Jose D; Negri Silvia; Brunet Salut; Lowenberg Bob; Sanz Miguel A
Central nervous system involvement at first relapse in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline monochemotherapy without intrathecal prophylaxis.
Haematologica 2009;94(9):1242-9.
-
2009: Delgado Julio; Pratt Guy; Phillips Neil; Briones Javier; Fegan Chris; Nomdedeu Josep; Pepper Chris; Aventin Anna; Ayats Ramon; Brunet Salut; Martino Rodrigo; Valcarcel David; Milligan Donald; Sierra Jorge
Beta2-microglobulin is a better predictor of treatment-free survival in patients with chronic lymphocytic leukaemia if adjusted according to glomerular filtration rate.
British journal of haematology 2009;145(6):801-5.
-
2009: Piñana Jose Luis; Valcárcel David; Martino Rodrigo; Barba Pere; Moreno Estela; Sureda Anna; Vega Monica; Delgado Julio; Briones Javier; Brunet Salut; Sierra Jorge
Study of kidney function impairment after reduced-intensity conditioning allogeneic hematopoietic stem cell transplantation. A single-center experience.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2009;15(1):21-9.
-
2009: Montesinos Pau; Bergua Juan M; Vellenga Edo; Rayón Chelo; Parody Ricardo; de la Serna Javier; León Angel; Esteve Jordi; Milone Gustavo; Debén Guillermo; Rivas Concha; González Marcos; Tormo Mar; Díaz-Mediavilla Joaquín; González Jose D; Negri Silvia; Amutio Elena; Brunet Salut; Lowenberg Bob; Sanz Miguel A
Differentiation syndrome in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and anthracycline chemotherapy: characteristics, outcome, and prognostic factors.
Blood 2009;113(4):775-83.
-
2009: Delgado J; Marco A; Moreno E; Piñana Jl; Valcarcel D; Martino R; Briones J; Sureda A; Brunet S; Sierra J
Reduced-intensity conditioning allogeneic hematopoietic cell transplantation using oral fludarabine as part of the conditioning regimen.
Cytotherapy 2009;11(3):356-61.
-
2008: Espinosa I; Briones J; Bordes R; Brunet S; Martino R; Sureda A; Sierra J; Prat J
Activation of the NF-kappaB signalling pathway in diffuse large B-cell lymphoma: clinical implications.
Histopathology 2008;53(4):441-9.
-
2008: Sanz Miguel A; Montesinos Pau; Vellenga Edo; Rayón Consuelo; de la Serna Javier; Parody Ricardo; Bergua Juan M; León Angel; Negri Silvia; González Marcos; Rivas Concha; Esteve Jordi; Milone Gustavo; González José D; Amutio Elena; Brunet Salut; García-Laraña J; Colomer Dolors; Calasanz María J; Chillón Carmen; Barragán Eva; Bolufer Pascual; Lowenberg Bob
Risk-adapted treatment of acute promyelocytic leukemia with all-trans retinoic acid and anthracycline monochemotherapy: long-term outcome of the LPA 99 multicenter study by the PETHEMA Group.
Blood 2008;112(8):3130-4.
-
2008: Carnicer Maria J; Lasa Adriana; Buschbeck Marcus; Serrano Elena; Carricondo Maite; Brunet Salut; Aventin Anna; Sierra Jorge; Di Croce Luciano; Nomdedeu Josep F
K313dup is a recurrent CEBPA mutation in de novo acute myeloid leukemia (AML).
Annals of hematology 2008;87(10):819-27.
-
2008: Oriol Albert; Ribera Josep-Maria; Bergua Juan; Giménez Mesa Eduardo; Grande Carlos; Esteve Jordi; Brunet Salut; Moreno Maria-Jose; Escoda Lourdes; Hernandez-Rivas Jesus-Maria; Hoelzer Dieter
High-dose chemotherapy and immunotherapy in adult Burkitt lymphoma: comparison of results in human immunodeficiency virus-infected and noninfected patients.
Cancer 2008;113(1):117-25.
-
2008: Casanova Isolda; Bosch Rosa; Lasa Adriana; Parreño Matilde; Céspedes María Virtudes; Brunet Salut; Nomdedéu Josep F; Mangues María Antònia; Sierra Jorge; Mangues Ramon
A celecoxib derivative inhibits focal adhesion signaling and induces caspase-8-dependent apoptosis in human acute myeloid leukemia cells.
International journal of cancer. Journal international du cancer 2008;123(1):217-26.
-
2008: Serrano Elena; Carnicer Maria J; Orantes Vanesa; Estivill Camino; Lasa Adriana; Brunet Salut; Aventín Anna M; Sierra Jorge; Nomdedéu Josep F
Uniparental disomy may be associated with microsatellite instability in acute myeloid leukemia (AML) with a normal karyotype.
Leukemia & lymphoma 2008;49(6):1178-83.
-
2008: Serrano Elena; Carnicer Maria J; Lasa Adriana; Orantes Vanesa; Pena Jorge; Brunet Salut; Aventín Anna; Sierra Jorge; Nomdedéu Josep F
Epigenetic-based treatments emphasize the biologic differences of core-binding factor acute myeloid leukemias.
Leukemia research 2008;32(6):944-53.
-
2008: de la Serna Javier; Montesinos Pau; Vellenga Edo; Rayón Chelo; Parody Ricardo; León Angel; Esteve Jordi; Bergua Juan M; Milone Gustavo; Debén Guillermo; Rivas Concha; González Marcos; Tormo Mar; Díaz-Mediavilla Joaquín; González Jose D; Negri Silvia; Amutio Elena; Brunet Salut; Lowenberg Bob; Sanz Miguel A
Causes and prognostic factors of remission induction failure in patients with acute promyelocytic leukemia treated with all-trans retinoic acid and idarubicin.
Blood 2008;111(7):3395-402.
-
2008: Lasa Adriana; Serrano Elena; Carricondo Maite; Carnicer Maria J; Brunet Salut; Badell Isabel; Sierra Jorge; Aventín Anna; Nomdedéu Josep F
High expression of CEACAM6 and CEACAM8 mRNA in acute lymphoblastic leukemias.
Annals of hematology 2008;87(3):205-11.
-
2008: Martino R; Valcárcel D; Brunet S; Sureda A; Sierra J
Comparable non-relapse mortality and survival after HLA-identical sibling blood stem cell transplantation with reduced or conventional-intensity preparative regimens for high-risk myelodysplasia or acute myeloid leukemia in first remission.
Bone marrow transplantation 2008;41(1):33-8.
-
2007: Pérez-García Arianne; De la Cámara Rafael; Román-Gómez Jose; Jiménez-Velasco Antonio; Encuentra Maite; Nieto Jose B; de la Rubia Javier; Urbano-Ispizúa Alvaro; Brunet Salut; Iriondo Arturo; González Marcos; Serrano David; Espigado Ildefonso; Solano Carlos; Ribera Josep M; Pujal Josep M; Hoyos Montserrat; Gallardo David;
CTLA-4 polymorphisms and clinical outcome after allogeneic stem cell transplantation from HLA-identical sibling donors.
Blood 2007;110(1):461-7.
-
2007: Jurado Manuel; Vallejo Carlos; Pérez-Simón José A; Brunet Salut; Ferra Christelle; Balsalobre Pascual; Pérez-Oteyza Jaime; Espigado Ildefonso; Romero Antonio; Caballero Dolores; Sierra Jorge; Ribera Jose M; Díez Jose L
Sirolimus as part of immunosuppressive therapy for refractory chronic graft-versus-host disease.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2007;13(6):701-6.
-
2007: Altes Albert; Remacha Angel Francisco; Sarda Pilar; Baiget Montserrat; Sureda Anna; Martino Rodrigo; Briones Javier; Brunet Salut; Canals Carme; Sierra Jorge
Early clinical impact of iron overload in stem cell transplantation. A prospective study.
Annals of hematology 2007;86(6):443-7.
-
2007: Esteve J; Escoda L; Martín G; Rubio V; Díaz-Mediavilla J; González M; Rivas C; Alvarez C; González San Miguel J D; Brunet S; Tomás J F; Tormo M; Sayas M J; Sánchez Godoy P; Colomer D; Bolufer P; Sanz M A;
Outcome of patients with acute promyelocytic leukemia failing to front-line treatment with all-trans retinoic acid and anthracycline-based chemotherapy (PETHEMA protocols LPA96 and LPA99): benefit of an early intervention.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2007;21(3):446-52.
-
2007: Bolufer Pascual; Collado Maria; Barragan Eva; Calasanz María-José; Colomer Dolors; Tormo Mar; González Marcos; Brunet Salut; Batlle Montserrat; Cervera José; Sanz Miguel-Angel
Profile of polymorphisms of drug-metabolising enzymes and the risk of therapy-related leukaemia.
British journal of haematology 2007;136(4):590-6.
-
2007: Sancho Juan-Manuel; Ribera Josep-Maria; Xicoy Blanca; Morgades Mireia; Oriol Albert; Tormo Mar; del Potro Eloy; Debén Guillermo; Abella Eugenia; Bethencourt Concepción; Ortín Xavier; Brunet Salut; Ortega-Rivas Fernando; Novo Andrés; López Ramón; Hernández-Rivas Jesús-María; Sanz Miguel-Angel; Feliu Evarist;
Results of the PETHEMA ALL-96 trial in elderly patients with Philadelphia chromosome-negative acute lymphoblastic leukemia.
European journal of haematology 2007;78(2):102-10.
-
2006: Piñana Jose Luis; Valcárcel David; Martino Rodrigo; Moreno M Estela; Sureda Anna; Briones Javier; Brunet Salut; Sierra Jorge
Encouraging results with inolimomab (anti-IL-2 receptor) as treatment for refractory acute graft-versus-host disease.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2006;12(11):1135-41.
-
2006: Espinosa Iñigo; Briones Javier; Bordes Ramon; Brunet Salut; Martino Rodrigo; Sureda Ana; Prat Jaime; Sierra Jorge
Membrane PKC-beta 2 protein expression predicts for poor response to chemotherapy and survival in patients with diffuse large B-cell lymphoma.
Annals of hematology 2006;85(9):597-603.
-
2006: Gallardo D; Pérez-García A; de la Cámara R; Iriondo A; Jiménez-Velasco A; Torres A; Brunet S; Urbano-Ispizúa A; Vallejo C; Encuentra M; Caballero D; Espigado I; Serrano D; Barrenetxea C; Ribera J M; de la Rubia J;
Clinical outcome after sex-mismatched allogeneic stem cell transplantation from human lymphocyte antigen-identical sibling donors: influence of stem cell source.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2006;20(8):1461-4.
-
2006: Clopés A; Sureda A; Sierra J; Queraltó J M; Broto A; Farré R; Moreno E; Brunet S; Martino R; Mangues M A
Absence of veno-occlussive disease in a cohort of multiple myeloma patients undergoing autologous stem cell transplantation with targeted busulfan dosage.
European journal of haematology 2006;77(1):1-6.
-
2006: Monzo Mariano; Brunet Salut; Urbano-Ispizua Alvaro; Navarro Alfons; Perea Granada; Esteve Jordi; Artells Rosa; Granell Miquel; Berlanga Juan; Ribera Josep M; Bueno Javier; Llorente Andreu; Guardia Ramon; Tormo Mar; Torres Pio; Nomdedéu Josep F; Montserrat Emili; Sierra Jordi;
Genomic polymorphisms provide prognostic information in intermediate-risk acute myeloblastic leukemia.
Blood 2006;107(12):4871-9.
-
2006: Pérez-Simón J A; Sureda A; Fernández-Aviles F; Sampol A; Cabrera J R; Caballero D; Martino R; Petit J; Tomás J F; Moraleda J M; Alegre A; Cañizo C; Brunet S; Rosiñol L; Lahuerta J; Díez-Martín J L; León A; García A; Vazquez L; Sierra J; San Miguel J F;
Reduced-intensity conditioning allogeneic transplantation is associated with a high incidence of extramedullary relapses in multiple myeloma patients.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2006;20(3):542-5.
-
2006: Perea G; Lasa A; Aventín A; Domingo A; Villamor N; Queipo de Llano M Paz; Llorente A; Juncà J; Palacios C; Fernández C; Gallart M; Font L; Tormo M; Florensa L; Bargay J; Martí J M; Vivancos P; Torres P; Berlanga J J; Badell I; Brunet S; Sierra J; Nomdedéu J F;
Prognostic value of minimal residual disease (MRD) in acute myeloid leukemia (AML) with favorable cytogenetics [t(8;21) and inv(16)].
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2006;20(1):87-94.
-
2006: Serrano Elena; Lasa Adriana; Perea Granada; Carnicer Maria J; Brunet Salut; Aventín Anna; Sierra Jorge; Nomdedéu Josep F
Acute myeloid leukemia subgroups identified by pathway-restricted gene expression signatures.
Acta haematologica 2006;116(2):77-89.
-
2005: Diaz M A; Gonzalez-Vicent M; Gonzalez M E; Verdeguer A; Martinez A; Perez-Hurtado M; Badell I; de la Rubia J; Bargay J; de Arriba F; Diez J L; Caballero D; Madero L; Brunet S;
Long-term outcome of allogeneic PBSC transplantation in pediatric patients with hematological malignancies: a report of the Spanish Working Party for Blood and Marrow Transplantation in Children (GETMON) and the Spanish Group for Allogeneic Peripheral Blood Transplantation (GETH).
Bone marrow transplantation 2005;36(9):781-5.
-
2005: Perea G; Domingo A; Villamor N; Palacios C; Juncà J; Torres P; Llorente A; Fernández C; Tormo M; Queipo de Llano M P; Bargay J; Gallart M; Florensa L; Vivancos P; Martí J M; Font Ll; Berlanga J; Esteve J; Bueno J; Ribera J M; Brunet S; Sierra J; Nomdedéu J F;
Adverse prognostic impact of CD36 and CD2 expression in adult de novo acute myeloid leukemia patients.
Leukemia research 2005;29(10):1109-16.
-
2005: Pérez-Simón José A; Díez-Campelo María; Martino Rodrigo; Brunet Salut; Urbano Alvaro; Caballero María D; de León Angel; Valcárcel David; Carreras Enric; del Cañizo María C; López-Fidalgo Jesús; Sierra Jordi; San Miguel Jesús F
Influence of the intensity of the conditioning regimen on the characteristics of acute and chronic graft-versus-host disease after allogeneic transplantation.
British journal of haematology 2005;130(3):394-403.
-
2005: Oriol Albert; Ribera Josep-Maria; Brunet Salut; del Potro Eloy; Abella Eugènia; Esteve Jordi
Highly active antiretroviral therapy and outcome of AIDS-related Burkitt's lymphoma or leukemia. Results of the PETHEMA-LAL3/97 study.
Haematologica 2005;90(7):990-2.
-
2005: Martino Rodrigo; Pérez-Simón José A; Moreno Estela; Queraltó José M; Caballero Dolores; Mateos Marivi; Sureda Anna; Cañizo Consuelo; Brunet Salut; Briones Javier; Vazquez Lourdes; Clopés Ana; San Miguel Jesús F; Sierra Jorge
Reduced-intensity conditioning allogeneic blood stem cell transplantation with fludarabine and oral busulfan with or without pharmacokinetically targeted busulfan dosing in patients with myeloid leukemia ineligible for conventional conditioning.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2005;11(6):437-47.
-
2005: Nomdedéu Josep F; Perea Granada; Estivill Camino; Lasa Adriana; Carnicer Maria J; Brunet Salut; Aventín Anna; Sierra Jorge
Microsatellite instability is not an uncommon finding in adult de novo acute myeloid leukemia.
Annals of hematology 2005;84(6):368-75.
-
2005: Valcárcel D; Martino R; Sureda A; Canals C; Altés A; Briones J; Sanz M A; Parody R; Constans M; Villela S L; Brunet S; Sierra J
Conventional versus reduced-intensity conditioning regimen for allogeneic stem cell transplantation in patients with hematological malignancies.
European journal of haematology 2005;74(2):144-51.
-
2004: Altes A; Remacha A F; Sarda P; Sancho F J; Sureda A; Martino R; Briones J; Brunet S; Canals C; Sierra J
Frequent severe liver iron overload after stem cell transplantation and its possible association with invasive aspergillosis.
Bone marrow transplantation 2004;34(6):505-9.
-
2004: Diaz M A; Vicent M G; Gonzalez M E; Verdeguer A; de la Rubia J; Bargay J; de Arriba F; Diez J L; Caballero D; Madero L; Brunet S;
Risk assessment and outcome of chronic graft-versus-host disease after allogeneic peripheral blood progenitor cell transplantation in pediatric patients.
Bone marrow transplantation 2004;34(5):433-8.
-
2004: Brunet Salut; Esteve Jordi; Berlanga Joan; Ribera Josep M; Bueno Javier; Martí Josep M; Bargay Joan; Guardia Ramon; Juliá Antoni; Granena Albert; Montserrat Emili; Sierra Jorge;
Treatment of primary acute myeloid leukemia: results of a prospective multicenter trial including high-dose cytarabine or stem cell transplantation as post-remission strategy.
Haematologica 2004;89(8):940-9.
-
2004: Casas Sílvia; Aventín Anna; Fuentes Francisca; Vallespí Teresa; Granada Isabel; Carrió Anna; Angel Martínez-Climent José; Solé Francesc; Teixidó Montserrat; Bernués Marta; Duarte José; Maria Hernández Jesús; Brunet Salut; Dolors Coll Maria; Sierra Jorge
Genetic diagnosis by comparative genomic hybridization in adult de novo acute myelocytic leukemia.
Cancer genetics and cytogenetics 2004;153(1):16-25.
-
2004: Oriol Albert; Ribera Josep-Maria; Esteve Jordi; Guàrdia Ramon; Brunet Salut; Bueno Javier; Pedro Carme; Llorente Andrés; Tormo Mar; Besalduch Joan; Sánchez Josep-Maria; Batlle Montserrat; Vivancos Pilar; Carreras Enric; Vilà Josep-Maria; Julià Antoni; Sierra Jordi; Montserrat Emili; Feliu Evarist;
Feasibility and results of autologous stem cell transplantation in de novo acute myeloid leukemia in patients over 60 years old. Results of the CETLAM AML-99 protocol.
Haematologica 2004;89(7):791-800.
-
2004: Lasa A; Carnicer M J; Aventín A; Estivill C; Brunet S; Sierra J; Nomdedéu J F
MEIS 1 expression is downregulated through promoter hypermethylation in AML1-ETO acute myeloid leukemias.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2004;18(7):1231-7.
-
2004: Gallardo D; De la Cámara R; Torres A; Brunet S; Jiménez A; Vallejo J C; Sanz G; Serrano D; Carreras E; Martín C; Sanz-Rodríguez C; Sierra J; Espigado I; Caballero D; Berlanga J J
Predicting survival for myeloid leukemia after HLA-identical sibling donor allogeneic stem cell transplantation.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2004;18(6):1165-7.
-
2004: Nomdedéu J F; Perea G; Estivill C; Lasa A; Brunet S; Aventín A; Sierra J
Loss of heterozygosity of the polymorphic PIG3 microsatellite with low frequency in de novo acute myeloid leukemias.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2004;18(6):1148-9.
-
2004: Gallardo D; De la Cámara R; Torres A; Brunet S; Jiménez A; Vallejo J C; Sanz G; Serrano D; Carreras E; Martín C; Sanz-Rodríguez C; Sierra J; Espigado I; Caballero D; Berlanga J J
Predicting survival for myeloid leukemia after HLA-identical sibling donor allogeneic stem cell transplantation.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2004;18(5):1031-4.
-
2004: Gallardo David; Brunet Salut; Torres Antonio; Alonso-Nieto Manuela; Vallejo Carlos; Jiménez Antonio; González Marcos; Sanz Guillermo; Serrano David; Espigado Ildefonso; Osorio Santiago; Carreras Enric; Martiín Carmen; Sanz-Rodríguez César; Sierra Jorge; Zuazu Javier; González-Escribano M Francisca; González Juan R; Román José; De Oteyza Jaime Pérez; De La Cámara Rafael
Hla-DPB1 mismatch in HLA-A-B-DRB1 identical sibling donor stem cell transplantation and acute graft-versus-host disease.
Transplantation 2004;77(7):1107-10.
-
2004: Miralbell Raymond; Sancho Gemma; Bieri Sabine; Carrió Ignasi; Helg Claudine; Brunet Salut; Martin Pierre-Yves; Sureda Anna; Gomez De Segura Gerard; Chapuis Bernard; Estorch Montserrat; Ozsahin Mahmut; Keller Alain
Renal insufficiency in patients with hematologic malignancies undergoing total body irradiation and bone marrow transplantation: a prospective assessment.
International journal of radiation oncology, biology, physics 2004;58(3):809-16.
-
2004: Carnicer Maria J; Nomdedéu Josep F; Lasa Adriana; Estivill Camino; Brunet Salut; Aventín Anna; Sierra Jorge
FLT3 mutations are associated with other molecular lesions in AML.
Leukemia research 2004;28(1):19-23.
-
2003: Schetelig Johannes; Fetscher Sebastian; Reichle Albrecht; Berdel Wolfgang E; Beguin Yves; Brunet Salut; Caballero Dolores; Majolino Ignazio; Hagberg Hans; Johnsen Hans E; Kimby Eva; Montserrat Emilio; Stewart Douglas; Copplestone Adrian; Rösler Wolf; Pavel Jindra; Kingreen Dorothea; Siegert Wolfgang
Long-term disease-free survival in patients with angioimmunoblastic T-cell lymphoma after high-dose chemotherapy and autologous stem cell transplantation.
Haematologica 2003;88(11):1272-8.
-
2003: del Cañizo M C; Martínez C; Conde E; Vallejo C; Brunet S; Sanz G; Mateos M V;
Peripheral blood is safer than bone marrow as a source of hematopoietic progenitors in patients with myelodysplastic syndromes who receive an allogeneic transplantation. Results from the Spanish registry.
Bone marrow transplantation 2003;32(10):987-92.
-
2003: Canals Carmen; Martino Rodrigo; Sureda Ana; Altés Albert; Briones Javier; Subirá Maricel; Ancín Idoia; Martín-Henao Gregorio; Brunet Salut; Sierra Jorge
Strategies to reduce transplant-related mortality after allogeneic stem cell transplantation in elderly patients: Comparison of reduced-intensity conditioning and unmanipulated peripheral blood stem cells vs a myeloablative regimen and CD34+ cell selection.
Experimental hematology 2003;31(11):1039-43.
-
2003: Subirà M; Sureda A; Ancín I; Martino R; Altés A; Brunet S; Sierra J
Allogeneic stem cell transplantation with reduced-intensity conditioning is potentially feasible as an outpatient procedure.
Bone marrow transplantation 2003;32(9):869-72.
-
2003: Xicoy Blanca; Ribera Josep-María; Esteve Jordi; Brunet Salut; Sanz Miguel-Angel; Fernández-Abellán Pascual; Feliu Evarist
Post-transplant Burkitt's leukemia or lymphoma. Study of five cases treated with specific intensive therapy (PETHEMA ALL-3/97 trial).
Leukemia & lymphoma 2003;44(9):1541-3.
-
2003: Pujol-Moix Núria; Brunet Salut; Ayats Ramón
Bone marrow necrosis with Charcot-Leyden crystals in a patient with idiopathic hypereosinophilic syndrome.
Haematologica 2003;88(9):EIM12.
-
2003: Díaz Miguel A; Sevilla Julián; de la Rubia Javier; Verdeguer Amparo; Espigado Ildefonso; Vicent Marta G; Pascual Maria J; Zamora Concha; Arrieta Rosario; Serrano David; del Cañizo Consuelo; Arbona Cristina; de Arriba Felipe; Bargay Joan; Brunet Salut; Sanz Miguel A
Factors predicting peripheral blood progenitor cell collection from pediatric donors for allogeneic transplantation.
Haematologica 2003;88(8):919-22.
-
2003: Perez-Simon Jose A; Diez-Campelo Maria; Martino Rodrigo; Sureda Anna; Caballero Dolores; Canizo Consuelo; Brunet Salut; Altes Albert; Vazquez Lourdes; Sierra Jordi; Miguel Jesus F San
Impact of CD34+ cell dose on the outcome of patients undergoing reduced-intensity-conditioning allogeneic peripheral blood stem cell transplantation.
Blood 2003;102(3):1108-13.
-
2003: Moscardó Federico; Urbano-Ispizua Alvaro; Sanz Guillermo F; Brunet Salut; Caballero Dolores; Vallejo Carlos; Solano Carlos; Pimentel Pedro; Pérez de Oteyza Jaime; Ferrá Christelle; Díez-Martín José L; Zuazu Javier; Espigado Ildefonso; Campilho Fernando; Arbona Cristina; Moraleda José M; Mateos María V; Sierra Jordi; Talarn Carmen; Sanz Miguel A
Positive selection for CD34+ reduces the incidence and severity of veno-occlusive disease of the liver after HLA-identical sibling allogeneic peripheral blood stem cell transplantation.
Experimental hematology 2003;31(6):545-50.
-
2003: Perea Granada; Altés Albert; Montoto Silvia; López-Guillermo Armando; Bosch Francesc; Jiménez Mónica; Esteve Jordi; Domingo Eva; Ribera Josep M; Pedro Carmen; Martino Rodrigo; Briones Javier; Sureda Anna; Brunet Salut; Sierra Jorge; Montserrat Emili
International and Italian prognostic indices in follicular lymphoma.
Haematologica 2003;88(6):700-4.
-
2003: Oriol Albert; Ribera Josep-Maria; Esteve Jordi; Sanz Miguel-Angel; Brunet Salut; Garcia-Boyero Raimundo; Fernández-Abellán Pascual; Martí Josep-Maria; Abella Eugènia; Sánchez-Delgado Magdalena; Peñarrubia Maria-Jesús; Besalduch Joan; Moreno Maria-José; Borrego Domingo; Feliu Evarist; Ortega Juan-José;
Lack of influence of human immunodeficiency virus infection status in the response to therapy and survival of adult patients with mature B-cell lymphoma or leukemia. Results of the PETHEMA-LAL3/97 study.
Haematologica 2003;88(4):445-53.
-
2003: Villela Luís; Sureda Anna; Canals Carme; Sanz Miguel Angel; Martino Rodrigo; Valcárcel David; Altés Albert; Briones Javier; Gómez Marta; Brunet Salut; Sierra Jorge
Low transplant related mortality in older patients with hematologic malignancies undergoing autologous stem cell transplantation.
Haematologica 2003;88(3):300-5.
-
2003: Oriol Albert; Ribera Josep-Maria; Brunet Salut; Esteve Jordi; Bueno Javier; Llorente Andrés
Oral induction and consolidation chemotherapy with idarubicin and etoposide in elderly patients with acute myeloid leukemia.
Haematologica 2003;88(2):229-30.
-
2003: Altes A; Remacha A F; Sureda A; Martino R; Briones J; Brunet S; Baiget M; Sierra J
Patients with biochemical iron overload: causes and characteristics of a cohort of 150 cases.
Annals of hematology 2003;82(2):127-30.
-
2003: Muñoz L; Nomdedéu J F; Villamor N; Guardia R; Colomer D; Ribera J M; Torres J P; Berlanga J J; Fernández C; Llorente A; Queipo de Llano M P; Sánchez J M; Brunet S; Sierra J;
Acute myeloid leukemia with MLL rearrangements: clinicobiological features, prognostic impact and value of flow cytometry in the detection of residual leukemic cells.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2003;17(1):76-82.
-
2002: Martino Rodrigo; Caballero María Dolores; Pérez-Simón José Antonio; Canals Carmen; Solano Carlos; Urbano-Ispízua Alvaro; Bargay Joan; Léon Angel; Sarrá Josep; Sanz Guillermo F; Moraleda José María; Brunet Salut; San Miguel Jesús; Sierra Jorge;
Evidence for a graft-versus-leukemia effect after allogeneic peripheral blood stem cell transplantation with reduced-intensity conditioning in acute myelogenous leukemia and myelodysplastic syndromes.
Blood 2002;100(6):2243-5.
-
2002: De la Rubia Javier; Arbona Cristina; Del Cañizo Consuelo; Arrieta Rosario; De Arriba Felipe; Pascual María J; Sanjuan Isabel; Díaz Miguel A; Brunet Salut; Alegre Adrián; Insunza Andrés; Espigado Ildefonso; Zamora Concha; De la Serna Javier; Serrano David; Bargay Joan; Petit José; Martínez Dobleta; Verdeguer Amparo; Ribera José M; Martínez Carmen; Benlloch Luis; Sanz Miguel A
Second mobilization and collection of peripheral blood progenitor cells in healthy donors is associated with lower CD34(+) cell yields.
Journal of hematotherapy & stem cell research 2002;11(4):705-9.
-
2002: Altès Albert; Sierra Jorge; Esteve Jordi; Martín-Henao Gregorio; Marín Pedro; Sureda Anna; Briones Javier; Martino Rodrigo; Villamor Neus; Colomer Dolors; Carreras Enric; Garcia J; Brunet Salut; Montserrat Emili
CD34+-enriched-CD19+-depleted autologous peripheral blood stem cell transplantation for chronic lymphoproliferative disorders: high purging efficiency but increased risk of severe infections.
Experimental hematology 2002;30(7):824-30.
-
2002: Urbano-Ispizua Alvaro; Rozman Ciril; Pimentel Pedro; Solano Carlos; de la Rubia Javier; Brunet Salut; Pérez-Oteyza Jaime; Ferrá Christelle; Zuazu Javier; Caballero Dolores; Bargay Joan; Carvalhais Alzira; Díez Jose Luis; Espigado Ildefonso; Alegre Adrián; Rovira Montserrat; Campilho Fernando; Odriozola Jesús; Sanz Miguel Angel; Sierra Jordi; García-Conde Javier; Montserrat Emili;
Risk factors for acute graft-versus-host disease in patients undergoing transplantation with CD34+ selected blood cells from HLA-identical siblings.
Blood 2002;100(2):724-7.
-
2002: Altès A; Remacha A F; Sureda A; Martino R; Briones J; Canals C; Brunet S; Sierra J; Gimferrer E
Iron overload might increase transplant-related mortality in haematopoietic stem cell transplantation.
Bone marrow transplantation 2002;29(12):987-9.
-
2002: Subirà Maricel; Martino Rodrigo; Franquet Tomás; Puzo Carmen; Altés Albert; Sureda Ana; Brunet Salut; Sierra Jorge
Invasive pulmonary aspergillosis in patients with hematologic malignancies: survival and prognostic factors.
Haematologica 2002;87(5):528-34.
-
2002: Arranz R; Conde E; Rodriguez-Salvanés F; Pajuelo F J; Cabrera R; Sanz M A; Petit J; Bueno J; Maldonado J; Odriozola J; Conde J G; Brunet S; Carreras E; Iriondo A; Fernández-Rañada J M; Marín P;
CsA-based post-graft immunosuppression: the main factor for improving outcome of allografted patients with acquired aplastic anemia. A retrospective survey by the Spanish Group of Hematopoietic Transplantation.
Bone marrow transplantation 2002;29(3):205-11.
-
2002: Martino Rodrigo; Subirá Maricel; Rovira Montserrat; Solano Carlos; Vázquez Lourdes; Sanz Guillermo F; Urbano-Ispizua Alvaro; Brunet Salut; De la Cámara Rafael;
Invasive fungal infections after allogeneic peripheral blood stem cell transplantation: incidence and risk factors in 395 patients.
British journal of haematology 2002;116(2):475-82.
-
2002: de la Rubia Javier; Arbona Cristina; de Arriba Felipe; del Cañizo Consuelo; Brunet Salut; Zamora Concha; Díaz Miguel A; Bargay Joan; Petit José; de la Serna Javier; Insunza Andrés; Arrieta Rosario; Pascual María J; Serrano David; Sanjuan Isabel; Espigado Ildefonso; Alegre Adrián; Martínez Dobleta; Verdeguer Amparo; Martínez Carmen; Benlloch Luis; Sanz Miguel A;
Analysis of factors associated with low peripheral blood progenitor cell collection in normal donors.
Transfusion 2002;42(1):4-9.
-
2001: Cervantes F; Sureda A; Hernández-Boluda J C; Martino R; Brunet S; Borrego D; Antich J L; Montserrat E
Interferon alpha plus intermittent oral Ara-C ocfosfate (YNK-01) in chronic myeloid leukemia primarily resistant or with minimal cytogenetic response to interferon.
Haematologica 2001;86(12):1281-6.
-
2001: Muñoz L; Nomdedéu J F; López O; Carnicer M J; Bellido M; Aventín A; Brunet S; Sierra J
Interleukin-3 receptor alpha chain (CD123) is widely expressed in hematologic malignancies.
Haematologica 2001;86(12):1261-9.
-
2001: Subirà M; Martino R; Sureda A; Altés A; Briones J; Brunet S; Sierra J
Safety and efficacy of low-dose amphotericin B lipid complex for empirical antifungal therapy of neutropenic fever in patients with hematologic malignancies.
Methods and findings in experimental and clinical pharmacology 2001;23(9):505-10.
-
2001: Perea G; Sureda A; Martino R; Altés A; Martínez C; Cabezudo E; Amill B; Martín-Henao G A; González Y; Muñoz L; Peyret M; Brunet S; Sierra J
Predictive factors for a successful mobilization of peripheral blood CD34+ cells in multiple myeloma.
Annals of hematology 2001;80(10):592-7.
-
2001: Martino R; Rovira M; Carreras E; Solano C; Jorge S; De La Rubia J; Caballero M D; de Oteyza J P; Zuazu J; Moraleda J M; Ojeda E; Ferrá C; Serrano D; De La Cámara R; Urbano-Ispízua A; Brunet S;
Severe infections after allogeneic peripheral blood stem cell transplantation: a matched-pair comparison of unmanipulated and CD34+ cell-selected transplantation.
Haematologica 2001;86(10):1075-86.
-
2001: Gallardo D; Aróstegui J I; Balas A; Torres A; Caballero D; Carreras E; Brunet S; Jiménez A; Mataix R; Serrano D; Vallejo C; Sanz G; Solano C; Rodríguez-Luaces M; Marín J; Baro J; Sanz C; Román J; González M; Martorell J; Sierra J; Martín C; de la Cámara R; Grañena A;
Disparity for the minor histocompatibility antigen HA-1 is associated with an increased risk of acute graft-versus-host disease (GvHD) but it does not affect chronic GvHD incidence, disease-free survival or overall survival after allogeneic human leucocyte antigen-identical sibling donor transplantation.
British journal of haematology 2001;114(4):931-6.
-
2001: Brunet S; Urbano-Ispizua A; Ojeda E; Ruiz D; Moraleda J M; Díaz M A; Caballero D; Bargay J; de la Rubia J; Solano C; Zuazu J; Diez J L; de la Serna J; Espigado I; Alegre A; Torres J P; Jurado M; Fernández M; Vivancos P; Carreras E; Hernández F; Maldonado J; Sierra J; Rozman C;
Favourable effect of the combination of acute and chronic graft-versus-host disease on the outcome of allogeneic peripheral blood stem cell transplantation for advanced haematological malignancies.
British journal of haematology 2001;114(3):544-50.
-
2001: Urbano-Ispizua A; Brunet S; Solano C; Moraleda J M; Rovira M; Zuazu J; de La Rubia J; Bargay J; Caballero D; Díez-Martín J L; Ojeda E; Pérez de Oteiza J P; Ferrá C; Espigado I; Alegre A; de La Serna J; Torres P; Riu C; Odriozola J; Rozman C; Sierra J; García-Conde J; Montserrat E;
Allogeneic transplantation of CD34+-selected cells from peripheral blood in patients with myeloid malignancies in early phase: a case control comparison with unmodified peripheral blood transplantation.
Bone marrow transplantation 2001;28(4):349-54.
-
2001: Martino R; Caballero M D; Canals C; San Miguel J; Sierra J; Rovira M; Solano C; Bargay J; Pérez-Simon J; León A; Sarrá J; Brunet S; de la Cámara R;
Reduced-intensity conditioning reduces the risk of severe infections after allogeneic peripheral blood stem cell transplantation.
Bone marrow transplantation 2001;28(4):341-7.
-
2001: de La Rubia J; Díaz M A; Verdeguer A; Pascual M J; Arbona C; Arrieta R; Brunet S; Bargay J; Martínez C; Espigado I; Serrano D; Alegre A; de Arriba F; de La Serna J; Zamora C; Benlloch L; Sanz M A
Donor age-related differences in PBPC mobilization with rHuG-CSF.
Transfusion 2001;41(2):201-5.
-
2001: Urbano-Ispizua A; Rozman C; Pimentel P; Solano C; de la Rubia J; Brunet S; Pérez-Oteiza J; Ferrá C; Zuazu J; Caballero D; Carvalhais A; Díez J L; Espigado I; Martínez C; Campilho F; Sanz M A; Sierra J; García-Conde J; Montserrat E;
The number of donor CD3(+) cells is the most important factor for graft failure after allogeneic transplantation of CD34(+) selected cells from peripheral blood from HLA-identical siblings.
Blood 2001;97(2):383-7.
-
2001: Bladé J; San Miguel J F; Fontanillas M; Esteve J; Maldonado J; Alcalá A; Brunet S; García-Conde J; Besalduch J; Moro M J; Fernández-Calvo J; Conde E; Font L; Gardella S; Carnero M; Carbonell F; Martí J M; Hernández-Martín J; Ortega F; Besses C; Ribera J M; Trujillo J; Escudero M L; Rozman C; Estapé J; Montserrat E
Increased conventional chemotherapy does not improve survival in multiple myeloma: long-term results of two PETHEMA trials including 914 patients.
The hematology journal : the official journal of the European Haematology Association / EHA 2001;2(4):272-8.
-
2000: Martino R; Martín-Henao G; Sureda A; Altés A; Canals C; Brunet S; Sierra J
Allogeneic peripheral blood stem cell transplantation with CD34+-cell selection and delayed T-cell add-back in adults. Results of a single center pilot study.
Haematologica 2000;85(11):1165-71.
-
2000: Altés A; López R; Martino R; Martinez C; Cabezudo E; Muñoz L; Santamaría A; Perea G; Briones J; Salar A; Sureda A; Brunet S; Madoz P; Sierra J
Mobilization kinetics of peripheral blood progenitor cells after IAPVP-16 salvage chemotherapy plus G-CSF in lymphoproliferative disorders.
Bone marrow transplantation 2000;26(2):127-32.
-
2000: Muñoz L; López O; Martino R; Brunet S; Bellido M; Rubiol E; Sierra J; Nomdedéu J F
Combined use of reverse transcriptase polymerase chain reaction and flow cytometry to study minimal residual disease in Philadelphia positive acute lymphoblastic leukemia.
Haematologica 2000;85(7):704-10.
-
2000: Martín G; Barragán E; Bolufer P; Chillón C; García-Sanz R; Gómez T; Brunet S; González M; Sanz M A
Relevance of presenting white blood cell count and kinetics of molecular remission in the prognosis of acute myeloid leukemia with CBFbeta/MYH11 rearrangement.
Haematologica 2000;85(7):699-703.
-
2000: Perea G; Salar A; Altés A; Brunet S; Sierra J
Acute hepatomegaly with severe liver toxicity due to all-trans-retinoic acid.
Haematologica 2000;85(5):551-2.
-
2000: Subirà M; Sureda A; Martino R; García J; Altés A; Canals C; Domingo-Albós A; Brunet S; Sierra J
Autologous stem cell transplantation for high-risk Hodgkin's disease: improvement over time and impact of conditioning regimen.
Haematologica 2000;85(2):167-72.
-
2000: Martín-Henao G A; Picón M; Amill B; Querol S; González J R; Martínez C; Martino R; Ferrá C; Brunet S; Grañena A; Sierra J; García J
Isolation of CD34+ progenitor cells from peripheral blood by use of an automated immunomagnetic selection system: factors affecting the results.
Transfusion 2000;40(1):35-43.
-
1999: Sureda A; Petit J; Brunet S; Boqué C; Aventín A; Martino R; González J R; Amill B; Larriba I; Blanco A; Martín-Henao G A; Sierra J; Grañena A
Mini-ICE regimen as mobilization therapy for chronic myelogenous leukaemia patients at diagnosis.
Bone marrow transplantation 1999;24(12):1285-90.
-
1999: de la Rubia J; Martínez C; Solano C; Brunet S; Cascón P; Arrieta R; Alegre A; Bargay J; de Arriba F; Cañizo C; López J; Serrano D; Verdeguer A; Torrabadella M; Díaz M A; Insunza A; de la Serna J; Espigado I; Petit J; Martínez M; Benlloch L; Sanz M
Administration of recombinant human granulocyte colony-stimulating factor to normal donors: results of the Spanish National Donor Registry. Spanish Group of Allo-PBT.
Bone marrow transplantation 1999;24(7):723-8.
-
1999: López R; Martino R; Brunet S; Sureda A; Domingo-Albós A; Sierra J
Salvage chemotherapy with IAPVP-16 for advanced refractory or relapsed follicular lymphomas.
Haematologica 1999;84(10):911-6.
-
1999: Grañena A; Castellsagué X; Badell I; Ferra C; Ortega J; Brunet S; Puntí C; Sureda A; Picón M; Valls A; Rutllant M; García J
Autologous bone marrow transplantation for high risk acute lymphoblastic leukemia: clinical relevance of ex vivo bone marrow purging with monoclonal antibodies and complement.
Bone marrow transplantation 1999;24(6):621-7.
-
1999: Muñoz L; Martino R; Subirà M; Brunet S; Sureda A; Sierra J
Intensified prophylaxis of febrile neutropenia with ofloxacin plus rifampin during severe short-duration neutropenia in patients with lymphoma.
Leukemia & lymphoma 1999;34(5-6):585-9.
-
1999: Martino R; Romero P; Subirá M; Bellido M; Altés A; Sureda A; Brunet S; Badell I; Cubells J; Sierra J
Comparison of the classic Glucksberg criteria and the IBMTR Severity Index for grading acute graft-versus-host disease following HLA-identical sibling stem cell transplantation. International Bone Marrow Transplant Registry.
Bone marrow transplantation 1999;24(3):283-7.
-
1999: Martino R; Bellido M; Brunet S; Altés A; Sureda A; Guárdia R; Aventín A; Nomdedéu J F; Domingo-Albós A; Sierra J
Intensive salvage chemotherapy for primary refractory or first relapsed adult acute lymphoblastic leukemia: results of a prospective trial.
Haematologica 1999;84(6):505-10.
-
1999: Martino R; Subirá M; Domingo-Albós A; Sureda A; Brunet S; Sierra J
Low-dose amphotericin B lipid complex for the treatment of persistent fever of unknown origin in patients with hematologic malignancies and prolonged neutropenia.
Chemotherapy 1999;45(3):205-12.
-
1999: Martino R; Shah A; Romero P; Brunet S; Sierra J; Domingo-Albós A; Fruchtman S; Isola L
Allogeneic bone marrow transplantation for advanced Waldenstrom's macroglobulinemia.
Bone marrow transplantation 1999;23(7):747-9.
-
1999: López R; Martino R; Sureda A; Nomdedéu J; Briones J; Martin-Henao G; García J; Brunet S; Sierra J
Autologous stem cell transplantation in advanced follicular lymphoma. A single center experience.
Haematologica 1999;84(4):350-5.
-
1999: Martín-Henao G A; Picón M; Limón A; Carmona M; Amill B; Azqueta C; López R; González-Barca E; Grañena A; Brunet S; García J
Immunomagnetic bone marrow (BM) and peripheral blood progenitor cell (PBPC) purging in follicular lymphoma (FL).
Bone marrow transplantation 1999;23(6):579-87.
-
1999: Martino R; Guardia R; Altés A; Sureda A; Brunet S; Sierra J
Time sequential chemotherapy for primary refractory or relapsed adult acute myeloid leukemia: results of the phase II Gemia protocol.
Haematologica 1999;84(3):226-30.
-
1999: González Y; Martino R; Badell I; Pardo N; Sureda A; Brunet S; Sierra J; Rabella N
Pulmonary enterovirus infections in stem cell transplant recipients.
Bone marrow transplantation 1999;23(5):511-3.
-
1999: Wägner A M; Brunet S; Puig J; Ortega E; Subirà M; Puig M
Chlorambucil-induced inappropriate antidiuresis in a man with chronic lymphocytic leukemia.
Annals of hematology 1999;78(1):37-8.
-
1998: Solano C; Martinez C; Brunet S; Tomás J F; Urbano-Ispizua A; Zuazu J; Ojeda E; Bargay J; Moraleda J M; Bailen A; Sierra J; García-Conde J; Rozman C
Chronic graft-versus-host disease after allogeneic peripheral blood progenitor cell or bone marrow transplantation from matched related donors. A case-control study. Spanish Group of Allo-PBT.
Bone marrow transplantation 1998;22(12):1129-35.
-
1998: Manteiga R; Martino R; Sureda A; Labeaga R; Brunet S; Sierra J; Rabella N
Cytomegalovirus pp65 antigenemia-guided pre-emptive treatment with ganciclovir after allogeneic stem transplantation: a single-center experience.
Bone marrow transplantation 1998;22(9):899-904.
-
1998: Urbano-Ispizua A; Solano C; Brunet S; de la Rubia J; Odriozola J; Zuazu J; Figuera A; Caballero D; Martínez C; García J; Sanz G; Torrabadella M; Alegre A; Pérez-Oteiza J; Jurado M; Oyonarte S; Sierra J; García-Conde J; Rozman C
Allogeneic transplantation of selected CD34+ cells from peripheral blood: experience of 62 cases using immunoadsorption or immunomagnetic technique. Spanish Group of Allo-PBT.
Bone marrow transplantation 1998;22(6):519-25.
-
1998: Urbano-Ispizua A; Solano C; Brunet S; de la Rubia J; Odriozola J; Zuazu J; Figuera A; Caballero D; Martínez C; García J; Sanz G; Torrabadella M; Alegre A; Pérez-Oteiza J; Jurado M; Oyonarte S; Sierra J; García-Conde J; Rozman C
Allogeneic transplantation of purified CD34+ cells from peripheral blood: Spanish experience of 62 cases. Spanish Group of allo-PBT.
Bone marrow transplantation 1998;21 Suppl 3():S71-4.
-
1998: Nomdedéu J F; Baiget M; Gaidano G; Estivill C; Lasa A; Rubiol E; Mateu R; Bordes R; Brunet S; Saglio G; Soler J
p53 mutation in a case of blastic transformation of follicular lymphoma with double bcl-2 rearrangement (MBR and VCR).
Leukemia & lymphoma 1998;29(5-6):595-605.
-
1998: Martino R; Bellido M; Brunet S; Sureda A; Peyret M; Guárdia R; Altés A; Domingo-Albós A; Sierra J
Allogeneic or autologous stem cell transplantation following salvage chemotherapy for adults with refractory or relapsed acute lymphoblastic leukemia.
Bone marrow transplantation 1998;21(10):1023-7.
-
1998: Hernández J A; Martino R; Pericas R; Sureda A; Brunet S; Domingo-Albós A
Achromobacter xylosoxidans bacteremia in patients with hematologic malignancies.
Haematologica 1998;83(3):284-5.
-
1998: Ribera J M; Ortega J J; Oriol A; Fontanillas M; Hernández-Rivas J M; Brunet S; García-Conde J; Maldonado J; Zuazu J; Gardella S; Besalduch J; León P; Macià J; Domingo-Albós A; Feliu E; San Miguel J F
Late intensification chemotherapy has not improved the results of intensive chemotherapy in adult acute lymphoblastic leukemia. Results of a prospective multicenter randomized trial (PETHEMA ALL-89). Spanish Society of Hematology.
Haematologica 1998;83(3):222-30.
-
1998: Alegre A; Díaz-Mediavilla J; San-Miguel J; Martínez R; García Laraña J; Sureda A; Lahuerta J J; Morales D; Bladé J; Caballero D; De la Rubia J; Escudero A; Díez-Martín J L; Hernández-Navarro F; Rifón J; Odriozola J; Brunet S; De la Serna J; Besalduch J; Vidal M J; Solano C; Leon A; Sánchez J J; Martínez-Chamorro C; Fernández-Rañada J M
Autologous peripheral blood stem cell transplantation for multiple myeloma: a report of 259 cases from the Spanish Registry. Spanish Registry for Transplant in MM (Grupo Español de Trasplante Hematopoyético-GETH) and PETHEMA.
Bone marrow transplantation 1998;21(2):133-40.
-
1998: Martino R; Subira M; Altés A; López R; Sureda A; Domingo-Albós A; Pericas R; Brunet S
Effect of discontinuing prophylaxis with norfloxacin in patients with hematologic malignancies and severe neutropenia. A matched case-control study of the effect on infectious morbidity.
Acta haematologica 1998;99(4):206-11.
-
1997: Santamaría A; Sureda A; Martino R; Domingo-Albós A; Muñiz-Díaz E; Brunet S
Successful treatment of pure red cell aplasia after major ABO-incompatible T cell-depleted bone marrow transplantation with erythropoietin.
Bone marrow transplantation 1997;20(12):1105-7.
-
1997: Ferrà C; de Sanjosé S; Lastra C F; Martí F; Mariño E L; Sureda A; Brunet S; Gallardo D; Berlanga J J; García J; Grañena A
Pentoxifylline, ciprofloxacin and prednisone failed to prevent transplant-related toxicities in bone marrow transplant recipients and were associated with an increased incidence of infectious complications.
Bone marrow transplantation 1997;20(12):1075-80.
-
1997: Gallardo D; García-López J; Sureda A; Canals C; Ferra C; Cancelas J A; Berlanga J J; Brunet S; Boqué C; Picón M; Torrico C; Amill B; Martino R; Martínez C; Martín-Henao G; Domingo-Albós A; Grañena A
Low-dose donor CD8+ cells in the CD4-depleted graft prevent allogeneic marrow graft rejection and severe graft-versus-host disease for chronic myeloid leukemia patients in first chronic phase.
Bone marrow transplantation 1997;20(11):945-52.
-
1997: Martino R; Santamaría A; Pericas R; Sureda A; Brunet S
Acute rhabdomyolysis and myonecrosis complicating aeromonas bacteremia in neutropenic patients with hematologic malignancies: report of two cases.
Haematologica 1997;82(6):692-4.
-
1997: Urbano-Ispizua A; García-Conde J; Brunet S; Hernández F; Sanz G; Petit J; Bargay J; Figuera A; Rovira M; Solano C; Ojeda E; de la Rubia J; Rozman C
High incidence of chronic graft versus host disease after allogeneic peripheral blood progenitor cell transplantation. The Spanish Group of Allo-PBPCT.
Haematologica 1997;82(6):683-9.
-
1997: Martínez C; Sureda A; Martino R; Cancelas J A; Madoz P; García J; Brunet S
Efficient peripheral blood stem cell mobilization with low-dose G-CSF (50 microg/m2) after salvage chemotherapy for lymphoma.
Bone marrow transplantation 1997;20(10):855-8.
-
1997: Nomdedéu J F; Lete I; Baiget M; Lasa A; Estivill C; Rubiol E; Badell I; Pardo N; Cubells J; Mateu R; Brunet S; Bordes R; Soler J
Mutational analysis of p53 in 16 cases of acute lymphoblastic leukemia and Burkitt's lymphoma.
Haematologica 1997;82(5):550-4.
-
1997: Sureda A; Mataix R; Hernández-Navarro F; Jarque I; Lahuerta J J; Tomás J F; Brunet S; Caballero D; Conde E; León A; Fernández M N; López A; Maldonado J; Bengoechea E; Callís M; Carrera D; García-Conde J; García-Laraña J; Moraleda J M; Morey M; Rifón J; Sierra J; Torres A; Domingo-Albós A
Autologous stem cell transplantation for poor prognosis Hodgkin's disease in first complete remission: a retrospective study from the Spanish GEL-TAMO cooperative group.
Bone marrow transplantation 1997;20(4):283-8.
-
1997: Martino R; Lopez R; Sureda A; Brunet S; Domingo-Albós A
Risk of reactivation of a recent invasive fungal infection in patients with hematological malignancies undergoing further intensive chemo-radiotherapy. A single-center experience and review of the literature.
Haematologica 1997;82(3):297-304.
-
1997: Urbano-Ispizua A; Solano C; Brunet S; de la Rubia J; Odriozola J; Zuazu J; Figuera A; Caballero D; Martínez C; García J; Sanz G; Torrabadella M; Alegre A; Pérez-Oteyza J; Sierra J; García-Conde J; Rozman C
[Allogeneic transplant of CD34+ peripheral blood cells from HLA-identical donors: Spanish experience of 40 cases. Allo-Peripheral Blood Transplantation Group]
Sangre 1997;42 Suppl 1():44-5.
-
1997: Brunet S; Urbano-Ispizua A; Solano C; Ojeda E; Caballero D; Torrabadella M; de la Rubia J; Pérez-Oteiza J; Moraleda J; Espigado I; de la Serna J; Petit J; Bargay J; Mataix R; Vivancos P; Figuera A; Sierra J; Domingo-Albós A; Hernández F; García Conde J; Rozman C
[Allogenic transplant of non-manipulated hematopoietic progenitor peripheral blood cells. Spanish experience of 79 cases. Allo-Peripheral Blood Transplantation Group]
Sangre 1997;42 Suppl 1():42-3.
-
1996: Altès A; Muñiz-Díaz E; Pujol-Moix N; Mateo J; Fontcuberta J; Parra J; Brunet S; Madoz P
[Isolated thrombocytopenia in pregnancy. Etiopathogenic study and therapeutic approach in 60 patients]
Medicina clínica 1996;107(19):721-5.
-
1996: Martino R; Martínez C; Brunet S; Sureda A; López R; Domingo-Albós A
Tuberculosis in bone marrow transplant recipients: report of two cases and review of the literature.
Bone marrow transplantation 1996;18(4):809-12.
-
1996: Martino R; Martínez C; Pericas R; Salazar R; Solá C; Brunet S; Sureda A; Domingo-Albós A
Bacteremia due to glucose non-fermenting gram-negative bacilli in patients with hematological neoplasias and solid tumors.
European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology 1996;15(7):610-5.
-
1996: Martínez C; Martino R; Brunet S; Sureda A; Nomdedéu J; García A; Soler J; Domingo-Albós A
Allogeneic stem cell transplantation for advanced low-grade lymphoproliferative disorders: report of six cases.
Haematologica 1996;81(4):330-4.
-
1996: Urbano-Ispizua A; Solano C; Brunet S; Hernández F; Sanz G; Alegre A; Petit J; Besalduch J; Vivancos P; Díaz M A; Moraleda J M; Carreras E; Ojeda E; de la Rubia J; Benet I; Domingo-Albós A; García-Conde J; Rozman C
Allogeneic peripheral blood progenitor cell transplantation: analysis of short-term engraftment and acute GVHD incidence in 33 cases. allo-PBPCT Spanish Group.
Bone marrow transplantation 1996;18(1):35-40.
-
1996: Martínez E; Sureda A; Dalmases C D; Sánchez J A; Amill B; Tugues D; Sardá P; Miralles A; Brunet S; Domingo-Albós A; García J
Mobilization of peripheral blood progenitor cells by cyclophosphamide and rhGM-CSF in multiple myeloma.
Bone marrow transplantation 1996;18(1):1-7.
-
1996: Sierra J; Brunet S; Grañena A; Olivé T; Bueno J; Ribera J M; Petit J; Besses C; Llorente A; Guardia R; Macía J; Rovira M; Badell I; Vela E; Díaz de Heredia C; Vivancos P; Carreras E; Feliu E; Montserrat E; Julía A; Cubells J; Rozman C; Domingo A; Ortega J J
Feasibility and results of bone marrow transplantation after remission induction and intensification chemotherapy in de novo acute myeloid leukemia. Catalan Group for Bone Marrow Transplantation.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1996;14(4):1353-63.
-
1996: Martino R; Brunet S; Sureda A; Guàrdia R; Aventiín A; Soler J; Altés A; Domingo-Albós A
Hematopoietic growth factor (G-CSF or GM-CSF) after salvage chemotherapy in refractory or relapsed adult de novo acute leukemia.
Leukemia & lymphoma 1996;20(3-4):321-6.
-
1995: Martino R; Brunet S; García A; Sureda A; Soler J; Martínez C; Domingo-Albós A; Baiget M
Various patterns of chimerism after allogeneic bone marrow transplantation for advanced chronic lymphocytic leukemia.
Bone marrow transplantation 1995;16(6):783-6.
-
1995: Bellido M C; Martino R; Martínez C; Sureda A; Brunet S
Extrapulmonary tuberculosis and non-Hodgkin's lymphoma: coexistence in an abdominal lymph node.
Haematologica 1995;80(5):482-3.
-
1995: Martino R; Badell I; Brunet S; Sureda A; Torras A; Cubells J; Domingo-Albós A
High-dose busulfan and melphalan before bone marrow transplantation for acute nonlymphoblastic leukemia.
Bone marrow transplantation 1995;16(2):209-12.
-
1995: Martínez C; Mateu R; Sureda A; Brunet S; Amill B; Madoz P; Portos J M; Subirà M; García-López J; Domingo-Albós A
Peripheral blood stem cell mobilization following salvage chemotherapy (IAPVP-16) plus granulocyte colony-stimulating factor and autografting for non-Hodgkin's lymphoma.
Transplantation proceedings 1995;27(4):2355-6.
-
1995: Salazar R; Martino R; Sureda A; Brunet S; Subirá M; Domingo-Albós A
Catheter-related bacteremia due to Pseudomonas paucimobilis in neutropenic cancer patients: report of two cases.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1995;20(6):1573-4.
-
1995: Martino R; Subirá M; Manteiga R; Badell I; Argilés B; Sureda A; Brunet S
Viridans streptococcal bacteremia and viridans streptococcal shock syndrome in neutropenic patients: comparison between children and adults receiving chemotherapy or undergoing bone marrow transplantation.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1995;20(2):476-7.
-
1995: Martino R; Manteiga R; Sánchez I; Brunet S; Sureda A; Badell I; Argilés B; Subirá M; Bordes R; Domingo-Albós A
Viridans streptococcal shock syndrome during bone marrow transplantation.
Acta haematologica 1995;94(2):69-73.
-
1994: Martino R; Badell I; Brunet S; Sureda A; Nomdedéu J; Altés A; Ayats R; Cubells J; Baiget M; Domingo-Albós A
Second bone marrow transplantation for leukemia in untreated relapse.
Bone marrow transplantation 1994;14(4):589-93.
-
1994: Martino R; Altés A; Sureda A; Brunet S; Domingo-Albós A
Prevention of invasive fungal infections during bone marrow transplantation.
Annals of hematology 1994;69(3):157.
-
1994: Martino R; Altes A; Nomdedeu J; Sureda A; Brunet S; Lopez R; Domingo Albos A
Atypical presentation of pneumococcal pneumonia in a patient undergoing bone marrow transplantation for Hodgkin's disease.
Bone marrow transplantation 1994;14(1):174-5.
-
1994: Nomdedéu J; Martino R; Sureda A; Huidobro G; López R; Brunet S; Domingo-Albós A
Acute tumor lysis syndrome complicating conditioning therapy for bone marrow transplantation in a patient with chronic lymphocytic leukemia.
Bone marrow transplantation 1994;13(5):659-60.
-
1994: Altes A; Martinez C; Martino R; Sureda A; Brunet S; Badell I; Cubells J; Domingo A; Rutllant M; Soler J
Value of routine bone marrow aspirates for surveillance of remission in acute leukemia.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1994;8(4):713.
-
1994: Martino R; Nomdedéu J; Altés A; Sureda A; Brunet S; Martínez C; Domingo-Albós A
Successful bone marrow transplantation in patients with previous invasive fungal infections: report of four cases.
Bone marrow transplantation 1994;13(3):265-9.
-
1994: Altès A; Brunet S; Martinez C; Soler J; Ayats R; Sureda A; López R; Domingo A
Spontaneous splenic rupture as the initial manifestation of acute lymphoblastic leukaemia: immunophenotype and cytogenetics.
Annals of hematology 1994;68(3):143-4.
-
1994: Martino R; Sureda A; Ayats R; Muñiz-Díaz E; Altés A; Brunet S
Successful treatment of chronic autoimmune neutropenia with cyclosporin A.
Haematologica 1994;79(1):66-9.
-
1994: López R; Martino R; Pericas R; Altés A; Sureda A; Brunet S
Capnocytophaga bacteremia in neutropenic patients: report of two cases.
Acta haematologica 1994;92(1):46-7.
-
1994: Martino R; Altés A; Muñiz-Díaz E; Brunet S; Sureda A; Domingo-Albós A; Madoz P
Reduced transfusion requirements in a splenectomized patient undergoing bone marrow transplantation.
Acta haematologica 1994;92(3):167-8.
-
1994: Martino R; Nomdedéu J; Sureda A; Mateu R; Brunet S; Domingo-Albós A
Acute rhabdomyolysis complicating viridans streptococcal shock syndrome.
Acta haematologica 1994;92(3):140-1.
-
1994: Canals C; Picón M; Sanchez T; Torrico C; Amill B; Tugues D; Sierra J; Grañena A; Badell I; Brunet S
Autologous bone marrow transplantation for acute lymphoblastic leukemia: role of bone marrow purging.
Progress in clinical and biological research 1994;389():125-32.
-
1993: Martino R; Nomdedéu J F; Brunet S; Sureda A; Montagut M; Domingo-Albós A
[Rheumatologic manifestations of chronic myelomonocytic leukemia. Presentation of 2 cases]
Sangre 1993;38(6):493-6.
-
1993: Martino R; Brunet S; Sureda A; Mateu R; Altés A; Domingo-Albós A
Treatment of refractory and relapsed adult acute leukemia using a uniform chemotherapy protocol.
Leukemia & lymphoma 1993;11(5-6):393-8.
-
1993: Sierra J; Conde E; Iriondo A; Brunet S; Marín J; Pérez de Oteiza J; Caballero D; Martínez F; León A; García-Conde J
Frozen vs. nonfrozen bone marrow for autologous transplantation in lymphomas: a report from the Spanish GEL/TAMO Cooperative Group.
Annals of hematology 1993;67(3):111-4.
-
1993: Nomdedéu J; Brunet S; Martino R; Altés A; Ausina V; Domingo-Albós A
Successful treatment of pneumonia due to Scedosporium apiospermum with itraconazole: case report.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 1993;16(5):731-3.
-
1993: Brunet S; Sureda A; Mateu R; Domingo-Albós A
[Full-term pregnancy in a patient diagnosed with acute leukemia treated with a protocol including VP-16]
Medicina clínica 1993;100(19):757-8.
-
1993: Canals C; Marti J M; Martinez E; Sierra J; Punti C; Granena A; Domingo A; Cubells J; Brunet S; Badell I
Hematological recovery after autologous bone marrow transplantation in acute leukemia: predictive factors.
Journal of hematotherapy 1993;2(1):75-85.
-
1992: Sureda A; Brunet S; Lopez J J; Pardo N; Soler J; Garcia J; Madoz P; Ayats R; Mateo J; Domingo-Albos A
High-dose chemotherapy with bone marrow rescue for treatment of Hodgkin's disease.
Leukemia & lymphoma 1992;7 Suppl():29-31.
-
1992: Sureda A; Canals C; Badell I; Nomdedeu J; Llácer M; Brunet S; Sierra J; Grañena A; Cubells J; Domingo-Albós A
GM-CSF administration enhances granulocytic recovery in purged autologous bone marrow transplantation for acute lymphoblastic leukemia.
Progress in clinical and biological research 1992;377():315-20.
-
1990: Aventín A; Brunet S; de Andrés L; Bordes R; Moltó E; Domingo A; Pujol-Moix N
Translocation (3;21) in a patient with secondary hematological malignancy.
Cancer genetics and cytogenetics 1990;50(2):227-9.
-
1990: Domingo-Albós A; García J; Puig J; Brunet S; Ayats R; Pardo N; Soler J; Muñiz E; Badell I
[Treatment of resistant or relapsing Hodgkin's disease with high doses of chemotherapy followed by autologous bone marrow transplant]
Medicina clínica 1990;94(9):321-4.
-
1990: Aventin A; Mecucci C; Guanyabens C; Brunet S; Soler J; Bordes R; van den Berghe H
Variant t(2;18) translocation in a Burkitt conversion of follicular lymphoma.
British journal of haematology 1990;74(3):367-9.
-
1989: Zuazu I; Canals C; Sempere A; Martín S; Brunet S; Puig J; Fontcuberta J; Grau E
[Association of acute leukemia with disseminated intravascular coagulation in adults. Analysis of 14 cases]
Medicina clínica 1989;93(12):441-4.
-
1989: Ortuño F; Zuazu I; Bordes R; Brunet S; Puig J; Ayats R
[The value of the initial bone biopsy in chronic myeloproliferative syndromes. Review of 80 cases]
Sangre 1989;34(2):117-25.
-
1989: Soler J; Pujol-Moix N; Bosch M A; Guanyabens C; Aventin A; Boque C; Brunet S
Acute erythroblastic leukemia. Cytological, cytogenetic and phenotypic studies in one case.
Acta haematologica 1989;82(2):102-5.
-
1988: Aventin A; Viaplana J; Zuazu I; Brunet S; Pujol-Moix N
Philadelphia-positive chronic myeloid leukemia with translocation t(3;21)
Cancer genetics and cytogenetics 1988;35(1):133-4.
-
1987: Soler J; Brunet S; Bordes R; Rubiol E; Mitjavila M; Pujol-Moix N
[Acute megakaryoblastic leukemia (M7). Immunocytochemical and ultrastructural study of 2 cases]
Medicina clínica 1987;88(2):68-70.
-
1985: Soler J; Estivill X; Ayats R; Brunet S; Pujol-Moix N
Chronic T-cell lymphocytosis associated with pure red call aplasia, thymoma and hypogammaglobulinemia.
British journal of haematology 1985;61(3):582-4.
Sign-in to see more